Lung cancer
Conditions
Interventions
Case series:None
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pathological diagnosis of lung adenocarcinoma;DI\isease progression after chemotherapy or targeted theraphy has not yet begun; 2. Complete medical history and initial tumor samples; 3. Recurrence was defined as the clinical pathology or imaging evaluation of patients with recurrence; 4. Aged 18-80 years old; 5. According to the Eastern Cooperative Oncology Group(ECOG),the Performance Status(PS) score was 0-4; 6. The patient was fully informed and signed the informationed conset; 7. The patient had no previous tumor history before the initial diagnosis of lung adenocarcinoma.
Exclusion criteria
Exclusion criteria: 1. The patient received blood transfusion within 2 weeks; 2. Patients suffer from autoimmune disease,including but not limited to systemic lupus erythematosus,rheumatiod arthritis,Sjogren's syndrome; 3. The patient refused to participate in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Genes; | — |
Countries
China
Contacts
Public ContactHuijuan Cui
China-Japan Friendship Hospital
Outcome results
None listed